Related Experiment Video
Updated: Jul 28, 2026

Normothermic Ex Situ Heart Perfusion in Working Mode: Assessment of Cardiac Function and Metabolism
Published on: January 12, 2019
Hemodynamic evaluation of a chronically implanted, electrically powered left ventricular assist system: responses to
Insights
This study shows that an implantable left ventricular assist device (LVAD) can maintain normal cardiac output and systemic pressure during various stress conditions in calves. The device proved effective even during severe left ventricular dysfunction and circulatory collapse.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Devices
Background:
- Left ventricular assist devices (LVADs) are crucial for managing advanced heart failure.
- Evaluating LVAD performance under diverse hemodynamic conditions is essential for clinical application.
- Chronic implantation studies are vital for assessing long-term device efficacy and physiological impact.
Purpose of the Study:
- To assess the hemodynamic performance of a chronically implanted LVAD in calves.
- To evaluate the LVAD's ability to maintain cardiac output and systemic pressure under various physiological stress conditions.
- To determine the device's functional capacity across different loading and chronotropic states.
Main Methods:
- Hemodynamic stress testing was conducted in four calves with chronically implanted LVADs.
- Devices were powered via pneumatic or transcutaneous energy transmission systems.
- Comprehensive hemodynamic monitoring included cardiac output, ventricular pressures, and arterial pressures.
Main Results:
- LVAD maintained normal cardiac output and systemic pressures despite atrial/ventricular pacing.
- Nitroprusside or vena cava occlusion caused decreased left ventricular pressure but preserved mean arterial pressure.
- Phenylephrine increased mean arterial pressure without altering cardiac output or filling pressures.
- Ventricular fibrillation led to decreased left ventricular pressure, yet mean arterial pressure remained adequate.
Conclusions:
- The implantable, electrically powered LVAD effectively maintains cardiac output across diverse loading and chronotropic states.
- The LVAD demonstrates preload dependency but successfully preserves systemic pressure during severe left ventricular dysfunction and circulatory collapse.
- This study supports the potential of advanced LVAD technology for supporting circulation in critical conditions.
Abstract:
Hemodynamic stress testing was performed in four calves with a chronically implanted left ventricular assist device consisting of a double-valved pump interposed between the left ventricular apex and the descending thoracic aorta. The device was powered either pneumatically (n = 1) or with a transcutaneous energy transmission system (n = 3). Hemodynamic evaluation (cardiac output and right and left ventricular and pulmonary and carotid artery pressures) was carried out at baseline and during all hemodynamically stressed states. Atrial pacing and ventricular pacing to a heart rate of 140 beats/min resulted in no significant change in right or left heart filling pressures or cardiac output. Preload reduction with nitroprusside or transient inferior vena cava balloon occlusion resulted in a marked decrease in left ventricular pressure with preservation of mean arterial pressure. Phenylephrine administration resulted in a marked rise in mean arterial pressure with no change in cardiac output or filling pressure. Induction of ventricular fibrillation resulted in a decrease of mean left ventricular pressure to 11 +/- 8 mm Hg, but mean arterial pressure was maintained at greater than or equal to 50 mm Hg. It is concluded that a multicomponent, implantable, electrically powered assist system is capable of maintaining a normal cardiac output under a wide range of loading conditions and chronotropic states. Although this device is clearly preload dependent, it is capable of maintaining normal systemic pressures during conditions of severe left ventricular dysfunction and circulatory collapse.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy

